Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Outcomes of stage I non-small cell lung cancer patients treated with surgery versus radiation therapy within the NLST

Principal Investigator
Name
Omar Abdel-Rahman
Degrees
MD
Institution
Avicenna Oncology center
Position Title
Consultant and scientific director
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-445
Initial CDAS Request Approval
Oct 11, 2018
Title
Outcomes of stage I non-small cell lung cancer patients treated with surgery versus radiation therapy within the NLST
Summary
Surgical resection is the currently accepted standard curative treatment for stage I non-small cell lung cancer. However more recently, definitive radiation therapy (particularly through stereotactic body radiation therapy) is being advocated as an acceptable alternative in selected subsets of patients. This remains to be proved through prospective studies.
Aims

1. To determine the differences in all-cause of mortality as well as cancer-specific mortality between patients with stage I disease treated with surgery versus radiation therapy.
2. To determine the risk of second primary malignancy development following initial radical treatment of stage I lung cancer.

Collaborators

1. Dr. Omar Abdel-Rahman

Related Publications